Haematology | pharmaphorum

Skip to main content

Thursday 17 September 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Haematology

Partner Content

iStock 686370946

Partner Content

When science and biology combine – the outlook for ADCs in c...

Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents.

News

caplacizumab

Ablynx files blood disorder drug in EU

Caplacizumab could be biotech's first marketed drug.

News

Red blood cells moving in blood vessels with depth of field.

Roche enters blood diagnostic market, promises faster result...

Platform combines morphology analysis, cell counting and cell classification.

News

Roche Rituxan approval

As rituximab biosimilars close in, Roche showcases Gazyva su...

Roche faces competition against its blockbuster haematology drug

News

The ASH congress is one again being held in San Diego.

CAR-Ts to take centre stage at ASH haematology congress

Haematology is one of the most exciting areas in drug development today, with waves of new treatments emerging for hard-to-treat diseases.

News

Blood-generic-6

Novartis buys sickle cell biotech Selexys

Swiss pharma takes option on US biotech.

Load more results

Editor's Picks

FDA overrides adcomm and approves AZ's oral SERD

Novartis falls sharply on another major R&D setback

Could UK clinical trial revamp unlock closer ties with Canada?

FDA makes acting CDER, CBER chiefs permanent

UK review recommends 'L plates' for new healthcare AIs

News

Tarja Stenvall

Bavarian Nordic has found its new CEO

Six months after Paul Chaplin said he was stepping down as CEO of Bavarian Nordic, the Danish biopharma has named Tarja Stenvall to the role.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company